PUBLISHER: Grand View Research | PRODUCT CODE: 1529643
PUBLISHER: Grand View Research | PRODUCT CODE: 1529643
UK Health Check-up Market Size, Share & Trends Analysis Report By Test Type (Blood, Urine, Body Fluid Tests, Imaging-based Tests), By End-use (Enterprise, Individual), And Segment Forecasts, 2024 - 2030
UK Health Check-up Market Growth & Trends:
The UK health check-up market size is anticipated to reach USD 3.0 billion by 2030, growing at a CAGR of 6.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the rising prevalence of chronic diseases and the need to provide preventive screening solutions. For instance, according to UK Health indicators, the top four most prevalent chronic conditions in the UK for both men and women are allergies, hypertension, lower back disorders, and depression. Allergies emerged as the most frequently reported chronic issue among both genders, with rates of 30.4% for men and 36.0% for women. Nearly half of the UK population, comprising 45.7% of men and 50.1% of women, disclosed experiencing a persistent condition. A higher proportion of women (22.3%) indicated experiencing some activity limitations due to health issues in the past six months compared to men (18.5%).
Rising government initiatives to provide healthcare solutions is further anticipated to drive market growth. For instance, in February 2024, the National Health Service (NHS) announce the launch of a digital version of the health check-up program for citizens in England. This initiative, known as the NHS Health Check, is designed for individuals aged 40 to 74, which translates to approximately 15 million people across the country. The check-up process typically involves an appointment with a general practitioner (GP), where patients are assessed for potential risks related to type 2 diabetes, strokes, kidney disease, and certain forms of dementia.
Moreover, the introduction of telemedicine in general healthcare practices has fueled the demand for home-based testing solutions. The healthcare ecosystem's digital connectivity framework has further empowered the market during the COVID-19 pandemic. The rising incidence of life-threatening diseases is a major driver for the market. This includes the growing prevalence of non-communicable diseases, such as diabetes, hypertension, cancer, and cardiovascular diseases. This combination of the increased availability of telemedicine and home-based testing, the escalating prevalence of life-threatening diseases, and the need for early detection of asymptomatic conditions are collectively expected to drive the growth and expansion of the market. These factors have enabled individuals to manage their health proactively and have contributed to the overall development of the healthcare ecosystem during the COVID-19 pandemic and beyond.
Furthermore, the rising strategic initiatives undertaken by the key players in the market, such as enhancing healthcare services and fostering collaborations between the public and private sectors, are expected to drive the overall development and expansion of the market. Additionally, the introduction of direct-to-customer testing solutions is anticipated to contribute to the growth and accessibility of check-up services during the forecast period. For instance, in June 2023, NHS announced the launch of home-based digital health checks. This new digital health check has been introduced with the aim of delivering an additional one million checks in the first four years.
UK Health Check-up Market Report Highlights:
- Blood, urine, body fluid tests segment dominated the test type segment and is anticipated to grow at the fastest growth rate over the forecast period owing to the rising adoption and usage of blood, urine, and body fluid samples in preventive care diagnosis.
- Individuals dominated the end-use segment; this is attributed to the growing awareness for preventive health among the population.
- Out-of-pocket dominated the individual end-use segment owing to the rising out-of-pocket spending expenditure by customers for personal check-ups.
- Enterprise segment held a significant share in end-use segment owing to the growing number of companies providing insurance to their employees.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Test Type
- 1.2.2. End-use
- 1.2.3. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Test Type and End-use outlook
- 2.3. Competitive Insights
Chapter 3. UK Health Check-up Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing prevalence of diseases
- 3.2.1.2. Growing investments in population screening
- 3.2.1.3. Growing geriatric population
- 3.2.1.4. Adoption of digital technology
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost associated with screening
- 3.2.2.2. Psychological Factors And Knowledge, Attitudes, & Beliefs
- 3.2.3. Market challenge analysis
- 3.2.3.1. Lack of awareness
- 3.2.4. Market Opportunity Analysis
- 3.2.4.1. Rising medical tourism
- 3.2.1. Market Driver Analysis
- 3.3. UK Health Check-up Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's Five Forces
Chapter 4. UK Health Check-up Market: Test Type Estimates & Trend Analysis
- 4.1. UK Health Check-up Market: Test Type Dashboard
- 4.2. UK Health Check-up Market: Test Type Movement Analysis
- 4.3. UK Health Check-up Market by Test Type, Revenue
- 4.4. Blood, Urine, Body Fluid Tests
- 4.4.1. Blood, urine, body fluid tests market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Imaging-based tests (Xray, CT, US, MRI)
- 4.5.1. Imaging based tests (Xray, CT, US, MRI) market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Non-imaging Tests (ECG, CPET, NCS, EMG, EEG)
- 4.6.1. Non-imaging tests (ECG, CPET, NCS, EMG, EEG) market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. UK Health Check-up Market: End-use Estimates & Trend Analysis
- 5.1. UK Health Check-up Market: End-use Dashboard
- 5.2. UK Health Check-up Market: End-use Movement Analysis
- 5.3. UK Health Check-up Market by End-use, Revenue
- 5.4. Enterprise
- 5.4.1. Enterprise market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Private (Corporate) Sector
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Government Sector
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Insurance
- 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Individual
- 5.5.1. Individual market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.2. Out of Pocket- Direct Payment for Health Check
- 5.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5.3. Individual Health Insurance Plan
- 5.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Company/Competition Categorization
- 6.3. Vendor Landscape
- 6.3.1. List of key distributors and channel partners
- 6.3.2. Key customers
- 6.3.3. Key company market share analysis, 2023
- 6.3.4. Quest Diagnostics Incorporated
- 6.3.4.1. Company overview
- 6.3.4.2. Financial performance
- 6.3.4.3. Product benchmarking
- 6.3.4.4. Strategic initiatives
- 6.3.5. Laboratory Corporation of America Holdings
- 6.3.5.1. Company overview
- 6.3.5.2. Financial performance
- 6.3.5.3. Product benchmarking
- 6.3.5.4. Strategic initiatives
- 6.3.6. SYNLAB International GmbH
- 6.3.6.1. Company overview
- 6.3.6.2. Financial performance
- 6.3.6.3. Product benchmarking
- 6.3.6.4. Strategic initiatives
- 6.3.7. OPKO Health, Inc.
- 6.3.7.1. Company overview
- 6.3.7.2. Financial performance
- 6.3.7.3. Product benchmarking
- 6.3.7.4. Strategic initiatives
- 6.3.8. Eurofins Scientific
- 6.3.8.1. Company overview
- 6.3.8.2. Financial performance
- 6.3.8.3. Product benchmarking
- 6.3.8.4. Strategic initiatives
- 6.3.9. UNILABS
- 6.3.9.1. Company overview
- 6.3.9.2. Financial performance
- 6.3.9.3. Product benchmarking
- 6.3.9.4. Strategic initiatives
- 6.3.10. Sonic Healthcare Limited
- 6.3.10.1. Company overview
- 6.3.10.2. Financial performance
- 6.3.10.3. Product benchmarking
- 6.3.10.4. Strategic initiatives
- 6.3.11. ARUP Laboratories
- 6.3.11.1. Company overview
- 6.3.11.2. Financial performance
- 6.3.11.3. Product benchmarking
- 6.3.11.4. Strategic initiatives
- 6.3.12. Q2 Solutions
- 6.3.12.1. Company overview
- 6.3.12.2. Financial performance
- 6.3.12.3. Product benchmarking
- 6.3.12.4. Strategic initiatives
List of Tables
- Table 1 List of abbreviations
- Table 2 UK health check-up market, by test type, 2018 - 2030 (USD Million)
- Table 3 UK health check-up market, by end-use, 2018 - 2030 (USD Million)
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Primary interviews in North America
- Fig. 5 Primary interviews in Europe
- Fig. 6 Primary interviews in APAC
- Fig. 7 Primary interviews in Latin America
- Fig. 8 Primary interviews in MEA
- Fig. 9 Market research approaches
- Fig. 10 Value-chain-based sizing & forecasting
- Fig. 11 QFD modeling for market share assessment
- Fig. 12 Market formulation & validation
- Fig. 13 UK health check-up market: market outlook
- Fig. 14 Drug screening competitive insights
- Fig. 15 Parent market outlook
- Fig. 16 Related/ancillary market outlook
- Fig. 17 UK health check-up market driver impact
- Fig. 18 UK health check-up market restraint impact
- Fig. 19 UK health check-up market: Test type movement analysis
- Fig. 20 UK health check-up market: Test type outlook and key takeaways
- Fig. 21 Blood, urine, body fluids tests market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 22 Imaging-based tests (Xray, CT, US, MRI) estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 23 Non-imaging tests (ECG, CPET, NCS, EMG, EEG) estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 24 UK health check-up market: End-use movement analysis
- Fig. 25 UK health check-up market: End-use outlook and key takeaways
- Fig. 26 Enterprise market estimates and forecast, 2018 - 2030 (USD Million)
- Fig. 27 Individual estimates and forecast, 2018 - 2030 (USD Million)
